ArticleHorticulture research2026
Chloroplast-to-apoplast relocalization of MOC1 strengthens plant vascular immunity.
Article in Horticulture research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pathogenic bacteria deploy biofilm as a key virulence factor to cause plant vascular diseases, which are devastating to global agricultural practices. Extracellular DNA (eDNA) constitutes the backbone of bacterial biofilm and is key to biofilm stability, thereby representing as an attractive therapeutic target. Here, we engineered the plant chloroplast-localized Holliday junction (HJ) resolvase MOC1 by replacing its native chloroplast transit peptide with a secretory signal, successfully relocating it to the apoplast. Transgenic tomato and rice expressing secreted MOC1 exhibited robust resistance to bacterial wilt and bacterial blight, respectively, without growth or yield penalties. Additionally, we implemented bacterial pathogen-inducible promoters to achieve precisely spatial and temporal control over the resistance trait. Secreted MOC1 degrades eDNA
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.